metoprolol has been researched along with Hyperlipoproteinemias in 3 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a single-blind prospective study, patients with hyperlipoproteinemias of the types II a, II b or IV were examined for changes of their serum lipid levels under the treatment with 300 mg celiprolol or 200 mg metoprolol, respectively, for a period of 4 weeks." | 9.06 | [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia]. ( Pristautz, H; Stradner, F, 1986) |
| "In a single-blind prospective study, patients with hyperlipoproteinemias of the types II a, II b or IV were examined for changes of their serum lipid levels under the treatment with 300 mg celiprolol or 200 mg metoprolol, respectively, for a period of 4 weeks." | 5.06 | [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia]. ( Pristautz, H; Stradner, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durrington, PN | 1 |
| Brownlee, WC | 1 |
| Large, DM | 1 |
| Pristautz, H | 1 |
| Stradner, F | 1 |
| Schauer, UJ | 1 |
| Schauer, I | 1 |
2 trials available for metoprolol and Hyperlipoproteinemias
| Article | Year |
|---|---|
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cholesterol; Cholesterol, HDL; Female; Half-Life; Hear | 1985 |
[Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Celiprolol; Cholesterol; Clinical Trials as Topic; Huma | 1986 |
1 other study available for metoprolol and Hyperlipoproteinemias
| Article | Year |
|---|---|
[Lipoprotein metabolism and beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol, HDL; Humans; Hyperlipoproteinemias; Lipoproteins | 1987 |